CD40 signal blocking agent

US6369065B1 · kind B1 · utility

Assignee

• UCB S.A. · BE

Inventors

• Pierre Chatelain · Brussels, BE
• Anne Mignot · Braine-l'Alleud, BE
• Mark B. Taubman · Rochester, US
• Michel Goldman · Brussels, BE

Key dates

• Filing date: Nov 13, 2000
• Grant date: Apr 9, 2002
• Expiry date: Nov 13, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A CD40 signal blocking agent comprising, as an active ingredient, s-triazolo[1,5-a]pyrimidine derivative represented by the following formula (1) or a pharmaceutically acceptable salt thereof, is disclosed